|Written by Rob Goldman|
See why you should be bullish in April but prepared for declines in May. In fact, there are quite a few signs out there that signal a really strong April only to be followed by a drop in May due to the Sell in May and Go Away crowd using potentially poor earnings performances a trigger. In fact, we may reach a record we don’t want to reach next month which could spark a sell-off. Nonetheless, at least for now, a number of investment pros have now become decidedly bullish in just the past few days.
Not to be outdone, we introduce a new feature “Thumbs Up/Thumbs Down” where we profile to big name stocks. It’s pretty cool and amusing too, as we channel our inner Siskel and Ebert.
BULL MARKET COUNTDOWN?
All right, I concede that we were wrong last week when we talked about the waffling investors. Today, investors seem to feel that like in basketball it’s not how you start but how you finish. (See Villanova in the NCAA Championship game.) And as bad as the strat of Q1, it ended so strong, that it has to practically be a divine sign of things to come. Add in the fact that April is one of the strongest performing months of the year for the S&P 500 Index, and it is just ahead of the dreaded month of May that stocks rising this month are already a fait accompli.
I, too will throw my hat in the ring for the reasons above but I also am willing to take a different tack. We have railed for years that the unemployment number is complete bullshit due to the huge underemployed figure. If we are to believe that the Bureau of Labor Statistics figures are accurate, the U-6 number, which includes unemployed, part-time employed, and those who no longer seek employment has dropped from a high of 16.9% in 2010 to under 10% today. Anyway you slice it, that is progress. The problem for stocks is that “Sell in May and Go Away” is around the corner so the bullish environment may not be long-lasting.
The Stock Market Today
So I guess you could say that I am cautiously optimistic. As you can see from the table above, since we are comfortably above the DMAs for big cap stocks, that is clearly a bullish sign and a long time coming. Small caps, as usual, have lagged, but there is still value in this space as we have expressed in these pages ad nauseam. So, we have improving employment and underemployment figures, improving technical features, and even improved confidence, as evidenced by results issued by The Conference Board.
Other interesting events of note include positive (albeit technical) comments from the great Ralph Campora regarding the bullish outlook for stocks. Furthermore, since Q1 was so crazy, the belief is that this time around the whole “Sell in May and Go Away” strategy may be pushed out a few weeks.Since we have become accustomed to events turning on a dime, it may be useful to mention the IPO environment. The first quarter of 2016 was so poor…(how poor was it?)...well, it was so poor that we haven’t had a slower IPO market since the last recession. To put it in perspective, only $700M in 8 deals were raised and there are already filings for this quarter that dwarf that anemic figure. If I had to guess, I would say that investment bankers will work double time to get as many closed as possible by the end of the quarter. After all, the summer is not exactly known as IPO central. So, if you are a glass half full kind of investor, the next few weeks could be very rewarding.
Great info, insights, and hard-hitting stories make up this week’s Say What? feature...
Brilliant and scary for the U.S.
The New York Post
This story is just too good not to read.
The Daily Mail
A landmark hire?
Time for a negative story...
AAII Sentiment Survey (figures rounded)
This week we see that individual investors are really unsure of things. Nearly half of investors surveyed are Neutral and an equal number are Bullish or Bearish. Conversely, investment pros are decidedly bullish. Perhaps it has something to do with what we discussed in the earlier pages…
What is most interesting and what may be the fundamental “Sell in May” trigger is Q1 earnings decline. According to Factset, the average estimated earnings decline for 1Q16 is (-8.5%). That would be the first time we have experienced four consecutive earnings declines since 2008/2009. I would not be surprised to see Q2 have performance that is the opposite of Q1 (up big then down big).
Thumbs Up/Thumbs Down
We hope you don’t mind that we have elected to channel our inner Siskel and Ebert sot this week we give you thumbs up/thumbs down for big name stocks.
Our thumbs-up play is Tesla Motors, Inc. (NASDAQ – TSLA - $237.59). The stock is up 65% since the middle of February. This past week the Company announced its new product the Model 3, targeted at a lower price point than its other models starting at around $35,000. CEO Elon Musk announced Tesla has received an unprecedented 276,000 orders already. Sales of the new Model 3 should help Tesla meet or even exceed Wall Street revenue expectations of $8.5 billion this year, 60% higher than 2015. On the technical side the momentum does not appear to be slowing, as the short, intermediate, and long term EMA all are giving a very bullish signal. Finally, the Company is sitting on $1.2 billion in cash as of the end of 2015. This will be critical in funding new ventures this year. We believe the stock climbs back to the 52-week high of $285 over the next six months.
Our thumbs-down is Chipotle Mexican Grill (NYSE – CMG - $464.81). The problems with E Coli are still popping up all over the country and the Company needs to get its house in order. In a purely blatant attempt to divert attention away from the ongoing issues, the Company announced a new ‘better burger’ concept. We believe this is merely a dog and pony trick designed to give the appearance that all is well and there are plenty of growth ideas being generated by management no matter how silly they appear to be. Seriously, when you crave a juicy hamburger is Chipotle where you are headed?
CMG is down 3% this year. This number could a lot worse given the E Coli drama. EPS for 4Q15 was down over 44% from 3Q15. As earnings season approaches, another bad report could be a further detriment and hammer the stock. A short float of 11.5% is another poor sign. We believe CMG should be avoided for now, with a possible buy-in at $400.
1498 Reisterstown Road, Suite 286 Baltimore Maryland 21208 Phone: 410.609.7100
Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, unless noted, With some exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ. Goldman Small Cap Research members and contributors’ bios, certifications, and experience can be found on our website: www.goldmanresearch.com
This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces non-sponsored and sponsored (paid) investment research. Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
The Firm’s non-sponsored research publications category, Select Research, reflects the Firm’s internally generated stock ideas, along with economic, industry and market outlooks. In virtually all cases, stocks mentioned in Select Research offerings are listed on the NYSE or the NASDAQ. Publications in this category include the weekly newsletter The Goldman Guide, Market Monitor blogs, Special Reports, and premium products such as The 30-30 Report. Goldman Small Cap Research analysts are neither long nor short stocks mentioned in this newsletter.
Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored microcap research ideas that typically carry greater risks than those stocks covered in Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in company-specific Opportunity Research reports, updates and articles.
Goldman Small Cap Research has not been compensated for any content in this issue.
All information contained in this newsletter and in our reports were provided by the companies mentioned via news releases, filings, and their websites or generated from our own due diligence. Economic, market data and charts are provided by a variety of sources and are cited upon publication. Stock performance data and information are derived from Yahoo! Finance and other websites or sources, as noted. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, other firms, or other financial news outlets. Goldman Small Cap Research relied solely upon information provided by companies through filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, blog, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This newsletter does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
Separate from the factual content of our articles about the company featured in this newsletter, we may from time to time include our own opinions about the companies profiled herein, their businesses, markets and opportunities. Any opinions we may offer about the companies are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com.